Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Non-Invasive MRI and MRS Techniques for Assessing Therapeutic Response to Pre-surgical Chemotherapy in Breast Cancer Patients
Sponsor: M.D. Anderson Cancer Center
This observational or N/A phase trial investigates Breast Cancer and is currently completed. M.D. Anderson Cancer Center leads this study, which shows 17 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
17 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Mar 2022 — Nov 2022 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Dec 2021 — Mar 2022 [monthly]
Active Not Recruiting
▶ Show 12 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Jun 2019 — Feb 2020 [monthly]
Active Not Recruiting
-
Nov 2018 — Jun 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Oct 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .